Bivacor - About the company
Bivacor is a series B company based in Houston (United States), founded in 2008. It operates as a Developer of ventricular assist device (VAD). Bivacor has raised $28M in funding from One Ventures and Cormorant Asset Management. The company has 99 active competitors, including 58 funded and 13 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and CorWave.
Company Details
Developer of ventricular assist device (VAD). It is a compact device that uses rotary blood pump technology to provide the required cardiac output. It comprises a magnetically levitated rotor located between opposing pump casings. An external controller and batteries provide power to the internal device via a percutaneous driveline.
- Website
- bivacor.com
- Social
- Email ID
- *****@bivacor.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2008
Location
Houston, United States
Stage
Series B
Total Funding
$28M in 8 rounds
Latest Funding Round
Investors
Ranked
11th among 99 active competitors
Employee Count
77 as on Jun 30, 2026
Sign up to download Bivacor's company profile
Bivacor's funding and investors
Bivacor has raised a total funding of $28M over 8 rounds. Its first funding round was on Sep 01, 2017. Bivacor has 5 institutional investors.
Here is the list of recent funding rounds of Bivacor:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 23, 2024 | 2422770 | Series B | 1351614 | 7028366 | 5751699 | 1110368 |
Feb 20, 2024 | 8319609 | Grant (prize money) | 6236565 | 7446221 | 2952740 | |
Aug 01, 2023 | 4045722 | Grant (prize money) | 5158293 | 5997723 | 5105850 |
Access funding benchmarks and valuations. Sign up today!View details of Bivacor's funding rounds and investors
Bivacor's founders and board of directors
Founder? Claim ProfileBivacor's employee count trend
Bivacor has 77 employees as of Jun 26. Here is Bivacor's employee count trend over the years:
Uncover Bivacor's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bivacor's Competitors and alternates
Top competitors of Bivacor include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of Bivacor, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CVRx 2001, Minneapolis (United States), Public | Developer of implantable technology for hypertension and heart failure | $394M | 68/100 | |
2nd | Impulse Dynamics 1998, Marlton (United States), Series F | Provider of implantable device for treatment of chronic heart failure | $685M | 64/100 | |
3rd | Developer of implantable blood pumps for the treatment of heart failure | $127M | 61/100 | ||
4th |  Element Science 2013, San Francisco (United States), Series C | Wearable therapeutic device for treating sudden cardiac arrest | $193M | 61/100 | |
5th | SynCardia 2001, Tucson (United States), Public | Artificial heart | $72M | 60/100 | |
6th | Restore Medical 2016, Tel Aviv (Israel), Series B | Catheter-delivered implant for treatment of congestive heart failure | $32M | 58/100 | |
7th | InterShunt Technologies 2015, Louisiana (United States), Series B | Developer of cardiac catheter for the treatment of cardiac diseases | $26.6M | 57/100 | |
8th | Developer of an implantable cardiovascular device for treating heart failures | $51.9M | 57/100 | ||
9th | Corvia Medical 2009, Tewksbury (United States), Acquired | Developer of transcatheterally shunt for treating diastolic heart failure disease | $160M | 57/100 | |
10th | Reprieve Cardiovascular 2018, Milford (United States), Series B | Developer of decongestion management solution for acute decompensated heart failure patients | $150M | 56/100 | |
11th | Bivacor 2008, Houston (United States), Series B | Developer of ventricular assist device (VAD) | $28M | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Bivacor's competitors? Click here to see the top ones
Bivacor's Investments and acquisitions
Bivacor has made no investments or acquisitions yet.
Reports related to Bivacor
Here is the latest report on Bivacor's geography:
News related to Bivacor
Filter this listMedia has covered Bivacor for 1 event in last 1 year.
•
BiVACOR Total Artificial Heart Accepted into FDA’s Total Product Life Cycle (TAP) ProgramBusiness Wire•Aug 07, 2025•Bivacor
•
BiVACOR's Titanium Artificial Heart: 100-Day Success Outside HospitalBioTecNika•Apr 08, 2025•Bivacor
•
•
BiVACOR has filed a notice of an exempt offering of securities to raise $28 Million in New Equity Investment.intelligence360•Aug 20, 2024•Bivacor
•
BiVACOR Completes First-in-Human Total Artificial Heart ImplantMedical Product Outsourcing•Jul 25, 2024•Texasheart, Bivacor
•
•
BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive OfficerBusiness Wire•Jan 03, 2024•Bivacor
•
Artificial heart maker BiVacor names Axonics CEO as chair of its boardMassDevice•Dec 27, 2023•Bivacor, Axonics
•
•
BiVACOR Gets IDE OK for Feasibility Study of Total Artificial HeartMedical Product Outsourcing•Nov 30, 2023•Bivacor
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Bivacor
Explore our recently published companies
- Creative Gallery - 2026 founded, Unfunded company
- Kraehenbueschken - Unfunded company
- Grabmale-Lotz - Unfunded company
- Hotel-Steuer - Unfunded company
- Coachingmb - Unfunded company
- Zikomm - Germany based, Unfunded company
